NAHSV Healthlinko Private Limited has completed its first year of operations with strong business momentum, highlighting profitable growth, expanding patient reach and international expansion plans centered around its flagship healthcare platform, MediFyr.
Founded in April 2025, the company was established to build technology-enabled solutions that improve how patients access and navigate healthcare services. Over the past year, that vision has translated into measurable progress, with MediFyr emerging as a core driver of both impact and growth.
The company said more than 2,000 patients are currently served each month through MediFyr, supporting healthcare access, treatment discovery and patient coordination. This growth contributed to ₹65 lakh in revenue during the last quarter of the previous financial year, providing early evidence of demand for the company’s operating model.
NAHSV Healthlinko noted that these milestones were achieved while remaining bootstrapped and profitable, without raising outside investment. Management said building with financial discipline has allowed the company to scale on stronger fundamentals and focus on sustainable value creation.
Alongside MediFyr, the company continues to build a wider portfolio that includes Zerunio, WhatPregnant, HealthSetu and Unikorn, supporting a broader long-term strategy across digital health and wellness.
A major priority for the coming year is international scale. The company has already established hospital partnerships across Turkey, Egypt, Israel, Thailand, UAE and China, creating an early network intended to support cross-border healthcare access and expand MediFyr’s reach in global markets.
According to the company, these partnerships represent an important foundation for future growth and position MediFyr to participate in increasing demand for international healthcare connectivity.
“The first year was about building proof of concept and a sustainable foundation,” the company said in a statement. “The next chapter is about scale — expanding market reach, strengthening partnerships and growing MediFyr across geographies.”
Looking ahead, the company said priorities for year two include expanding patient volumes, strengthening technology capabilities, increasing strategic partnerships and accelerating international growth.
With early revenue traction, growing patient impact and international groundwork established, the company believes it is entering its second year positioned to expand both its domestic presence and global opportunities.
This press release is provided by a third party. The website does not verify its accuracy and is not responsible for its content or any resulting claims.
